Stakeholders Say CMS’ 2023 MA Proposed Rule Could Go Further

By Bridget Early / March 31, 2022 at 12:10 PM
Beneficiary advocates and providers argue CMS’ 2023 Medicare Advantage and Part D proposed rule doesn’t go far enough on network adequacy, plan oversight and special needs plans to support beneficiaries and rein in bad actors, but MA advocates and plans said the changes will create significant logistical burdens and unnecessary costs. Stakeholders last year eagerly watched for the Biden administration’s take on how it would handle Medicare Advantage ahead of the rule and the 2023 advanced notice and call letter...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.